and Answers | Pharmacology Study Guide, Practice Exam, Comprehensive
Review, Exam Prep Test Bank, Drug Classifications, Pharmacokinetics,
Pharmacodynamics, Medication Administration, Dosage Calculations,
Drug Interactions, Adverse Reactions, Patient Safety, NCLEX
Pharmacology Review, Detailed Rationales and Complete Revision
Material
Question 1: A patient with a history of peptic ulcer disease requires low-dose
aspirin for cardiovascular protection. Which co-administration strategy best
minimizes the risk of gastric mucosal injury while preserving antiplatelet efficacy?
A. Enteric-coated aspirin with a glass of milk
B. Immediate-release aspirin with a proton pump inhibitor (PPI)
C. Buffered aspirin with an H2-receptor antagonist
D. Aspirin with a COX-2 selective inhibitor
CORRECT ANSWER: B. Immediate-release aspirin with a proton pump inhibitor
(PPI)
Rationale: The concurrent use of a PPI (e.g., omeprazole) with low-dose aspirin is the
most effective strategy to reduce the risk of gastroduodenal ulcers. PPIs potently
suppress gastric acid secretion, which is crucial for preventing aspirin-induced
mucosal damage. Enteric coating is not fully reliable, and buffered agents are less
effective than PPIs. COX-2 inhibitors should not be co-administered with aspirin as they
may interfere with the antiplatelet effect.
Question 2: A patient on chronic lithium therapy develops coarse tremors, nausea,
and confusion. Serum lithium level is 2.1 mEq/L. Which acute intervention is most
critical to enhance lithium elimination?
A. Administer sodium polystyrene sulfonate
B. Increase dietary sodium intake
C. Administer mannitol
D. Initiate hemodialysis
CORRECT ANSWER: D. Initiate hemodialysis
Rationale: At a lithium level of 2.1 mEq/L with severe neurologic symptoms (toxicity),
hemodialysis is the most effective method for rapid removal of the drug. While mannitol
or increased sodium intake may help, they are not as definitive or rapid as hemodialysis
for severe toxicity. Sodium polystyrene sulfonate is not indicated for lithium.
Question 3: A 45-year-old male is prescribed a statin for hyperlipidemia. He also
takes amlodipine for hypertension. Which statin has the lowest risk of clinically
significant drug interaction with amlodipine?
A. Atorvastatin
B. Lovastatin
,C. Simvastatin
D. Pravastatin
CORRECT ANSWER: D. Pravastatin
Rationale: Pravastatin is not significantly metabolized by the CYP3A4 enzyme system,
which is inhibited by amlodipine. Therefore, it has a much lower risk of interaction
compared to atorvastatin, lovastatin, and simvastatin, which are CYP3A4 substrates
and can have increased plasma concentrations when co-administered with amlodipine.
Question 4: A patient with type 2 diabetes mellitus is started on metformin. What is
the most important laboratory parameter to monitor prior to initiating therapy to
prevent a life-threatening adverse effect?
A. Liver function tests
B. Serum creatinine and eGFR
C. Serum potassium
D. Complete blood count
CORRECT ANSWER: B. Serum creatinine and eGFR
Rationale: Metformin carries a risk of lactic acidosis, a life-threatening adverse effect,
particularly in patients with renal impairment. Assessing renal function (serum
creatinine and eGFR) is mandatory before initiation and periodically thereafter to ensure
the drug is safe and appropriately dosed.
Question 5: A 28-year-old woman with a history of major depressive disorder is
prescribed an SSRI. She reports experiencing bruxism (teeth grinding) since
starting the medication. Which pharmacological agent is most commonly used to
manage SSRI-induced bruxism?
A. Buspirone
B. Propranolol
C. Diphenhydramine
D. Amantadine
CORRECT ANSWER: A. Buspirone
Rationale: Buspirone, a 5-HT1A receptor partial agonist, has shown efficacy in
managing SSRI-induced bruxism. It is often added to the SSRI regimen to counteract
this side effect. Propranolol and amantadine are sometimes used for other movement
disorders, while diphenhydramine is generally ineffective for this specific indication.
Question 6: A 60-year-old patient with chronic obstructive pulmonary disease
(COPD) is prescribed tiotropium. Which mechanism of action correctly describes
this medication?
A. Beta-2 adrenergic receptor agonist
B. Phosphodiesterase-4 inhibitor
,C. Long-acting muscarinic antagonist
D. Corticosteroid
CORRECT ANSWER: C. Long-acting muscarinic antagonist
Rationale: Tiotropium is a long-acting muscarinic antagonist (LAMA) that blocks the M3
receptors in the bronchial smooth muscle, leading to bronchodilation. It is not a beta-
agonist, PDE-4 inhibitor, or corticosteroid.
Question 7: A patient is receiving vancomycin for a severe MRSA infection. The
serum trough level is reported as 22 mcg/mL. What is the most appropriate next
step?
A. Continue the current dose and monitor
B. Increase the dose to achieve a higher trough
C. Hold the next dose and consider dose adjustment
D. Switch to oral vancomycin
CORRECT ANSWER: C. Hold the next dose and consider dose adjustment
Rationale: The target trough for serious MRSA infections is typically 15-20 mcg/mL. A
level of 22 mcg/mL is above the therapeutic range and increases the risk of
nephrotoxicity. The next dose should be held, and the dose or interval should be
adjusted based on the patient's renal function and the clinical scenario.
Question 8: A 35-year-old male with generalized anxiety disorder is started on
venlafaxine. Which adverse effect is most concerning and requires monitoring of
blood pressure?
A. Orthostatic hypotension
B. Sustained hypertension
C. Bradycardia
D. Palpitations
CORRECT ANSWER: B. Sustained hypertension
Rationale: Venlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI), can
cause a dose-dependent increase in blood pressure. Sustained hypertension is a well-
documented and significant adverse effect requiring regular monitoring, especially at
higher doses.
Question 9: A patient on warfarin therapy presents with an INR of 6.5. He has no
signs of bleeding. Which management strategy is most appropriate?
A. Administer vitamin K 10 mg subcutaneously
B. Administer fresh frozen plasma
C. Hold warfarin and consider low-dose oral vitamin K
D. Administer prothrombin complex concentrate
CORRECT ANSWER: C. Hold warfarin and consider low-dose oral vitamin K
, Rationale: For an INR between 5.0 and 9.0 without bleeding, the standard
recommendation is to hold warfarin and consider administering low-dose oral vitamin K
(1-2.5 mg) to lower the INR, especially if the patient is at high risk for bleeding. High-
dose vitamin K (10 mg) is typically reserved for patients with major bleeding.
Question 10: A child is prescribed amoxicillin for acute otitis media. The mother
reports a previous rash after taking penicillin. What is the most appropriate initial
action?
A. Prescribe amoxicillin with an antihistamine
B. Prescribe amoxicillin-clavulanate
C. Refer for allergy testing or choose an alternative antibiotic
D. Administer a test dose of amoxicillin in the clinic
CORRECT ANSWER: C. Refer for allergy testing or choose an alternative antibiotic
Rationale: A history of a rash after penicillin could indicate a hypersensitivity reaction.
It is safest to avoid penicillin-class antibiotics (including amoxicillin) until a true allergy
can be confirmed or ruled out with allergy testing. An alternative antibiotic such as a
cephalosporin (with caution) or macrolide may be considered.
Question 11: A patient with acute gout is prescribed colchicine. Which adverse
effect is most commonly dose-limiting?
A. Nephrotoxicity
B. Hepatotoxicity
C. Gastrointestinal distress (diarrhea, nausea)
D. Myelosuppression
CORRECT ANSWER: C. Gastrointestinal distress (diarrhea, nausea)
Rationale: Gastrointestinal side effects, particularly diarrhea and nausea, are the most
common and dose-limiting adverse effects of colchicine. While other effects can occur,
GI distress is the most frequent reason for dose reduction or discontinuation.
Question 12: A 72-year-old patient is started on rivaroxaban for non-valvular atrial
fibrillation. What is the recommended dose for this patient if her creatinine
clearance is 48 mL/min?
A. 20 mg once daily
B. 15 mg once daily
C. 10 mg once daily
D. 5 mg twice daily
CORRECT ANSWER: B. 15 mg once daily
Rationale: For patients with non-valvular atrial fibrillation and a creatinine clearance of
15-50 mL/min, the recommended dose of rivaroxaban is 15 mg once daily. For patients
with a CrCl > 50 mL/min, the dose is 20 mg once daily.